$AVGN Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in AVIGEN INC \DE.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in AVIGEN INC \DE. Get notifications about new insider transactions in AVIGEN INC \DE for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 06 2007 | AVGN | AVIGEN INC \DE | Thomson Mary Christina | VP, Corp Counsel & ... | Buy | M | 3.38 | 4,000 | 13,520 | 4,000 | 0 to 4 K |
Apr 12 2007 | AVGN | AVIGEN INC \DE | Thomson Mary Christina | VP, Corp Counsel & ... | Option Exercise | M | 3.38 | 4,000 | 13,520 | 96,000 | |
Apr 12 2007 | AVGN | AVIGEN INC \DE | Thomson Mary Christina | VP, Corp Counsel & ... | Sell | S | 7.00 | 4,000 | 28,000 | 0 | 4 K to 0 (-100.00 %) |
Apr 12 2007 | AVGN | AVIGEN INC \DE | Thomson Mary Christina | VP, Corp Counsel & ... | Buy | M | 3.38 | 4,000 | 13,520 | 4,000 | 0 to 4 K |
Feb 26 2007 | AVGN | AVIGEN INC \DE | HOROVITZ ZOLA P | Director | Option Exercise | M | 3.25 | 5,000 | 16,250 | 0 | |
Feb 26 2007 | AVGN | AVIGEN INC \DE | HOROVITZ ZOLA P | Director | Buy | M | 3.25 | 5,000 | 16,250 | 5,000 | 0 to 5 K |
Mar 22 2007 | AVGN | AVIGEN INC \DE | PRENDERGAST JOHN K A | Director | Sell | S | 6.70 | 200 | 1,340 | 46,608 | 46.8 K to 46.6 K (-0.43 %) |
Mar 22 2007 | AVGN | AVIGEN INC \DE | PRENDERGAST JOHN K A | Director | Sell | S | 6.69 | 100 | 669 | 46,808 | 46.9 K to 46.8 K (-0.21 %) |
Mar 22 2007 | AVGN | AVIGEN INC \DE | PRENDERGAST JOHN K A | Director | Sell | S | 6.65 | 100 | 665 | 46,908 | 47 K to 46.9 K (-0.21 %) |
Mar 22 2007 | AVGN | AVIGEN INC \DE | PRENDERGAST JOHN K A | Director | Sell | S | 6.61 | 1,100 | 7,271 | 47,008 | 48.1 K to 47 K (-2.29 %) |
Mar 22 2007 | AVGN | AVIGEN INC \DE | PRENDERGAST JOHN K A | Director | Sell | S | 6.50 | 2,692 | 17,498 | 48,108 | 50.8 K to 48.1 K (-5.30 %) |
Mar 22 2007 | AVGN | AVIGEN INC \DE | PRENDERGAST JOHN K A | Director | Sell | S | 6.50 | 300 | 1,950 | 50,800 | 51.1 K to 50.8 K (-0.59 %) |
Mar 22 2007 | AVGN | AVIGEN INC \DE | PRENDERGAST JOHN K A | Director | Sell | S | 6.65 | 7,508 | 49,928 | 51,100 | 58.6 K to 51.1 K (-12.81 %) |
Mar 02 2007 | AVGN | AVIGEN INC \DE | SAUTER ANDREW AUGUST | VP, Finance | Option Exercise | M | 3.45 | 4,000 | 13,800 | 11,000 | |
Mar 02 2007 | AVGN | AVIGEN INC \DE | SAUTER ANDREW AUGUST | VP, Finance | Buy | M | 3.45 | 4,000 | 13,800 | 4,125 | 125 to 4.1 K (+3,200.00 %) |
Mar 09 2007 | AVGN | AVIGEN INC \DE | Thomson Mary Christina | VP, Corp Counsel & ... | Option Exercise | M | 3.14 | 5,000 | 15,700 | 11,500 | |
Mar 09 2007 | AVGN | AVIGEN INC \DE | Thomson Mary Christina | VP, Corp Counsel & ... | Sell | S | 7.00 | 5,000 | 35,000 | 0 | 5 K to 0 (-100.00 %) |
Mar 09 2007 | AVGN | AVIGEN INC \DE | Thomson Mary Christina | VP, Corp Counsel & ... | Buy | M | 3.14 | 5,000 | 15,700 | 5,000 | 0 to 5 K |
Feb 06 2007 | AVGN | AVIGEN INC \DE | OHRSTROM JAN K | Director | Option Exercise | A | 6.04 | 30,000 | 181,200 | 30,000 | |
Jan 05 2007 | AVGN | AVIGEN INC \DE | SAUTER ANDREW AUGUST | VP, Finance | Option Exercise | A | 5.50 | 65,000 | 357,500 | 65,000 | |
Feb 06 2007 | AVGN | AVIGEN INC \DE | DILLY STEPHEN GEORGE | Director | Option Exercise | A | 6.04 | 30,000 | 181,200 | 30,000 | |
Jan 05 2007 | AVGN | AVIGEN INC \DE | Johnson Kirk William | VP, Research & Deve ... | Option Exercise | A | 5.50 | 70,000 | 385,000 | 70,000 | |
Jan 05 2007 | AVGN | AVIGEN INC \DE | Thomson Mary Christina | VP, Corp Counsel & ... | Option Exercise | A | 5.50 | 65,000 | 357,500 | 65,000 | |
Jan 05 2007 | AVGN | AVIGEN INC \DE | COFFEE MICHAEL DENIS | Chief Business Offi ... | Option Exercise | A | 5.50 | 65,000 | 357,500 | 65,000 | |
Jan 05 2007 | AVGN | AVIGEN INC \DE | CHAHINE KENNETH | Chief Executive Off ... | Option Exercise | A | 5.50 | 90,000 | 495,000 | 90,000 | |
Nov 28 2006 | AVGN | AVIGEN INC \DE | IWAKI YUICHI | Director | Sell | S | 5.91 | 200 | 1,182 | 39,621 | 39.8 K to 39.6 K (-0.50 %) |
Nov 28 2006 | AVGN | AVIGEN INC \DE | IWAKI YUICHI | Director | Sell | S | 5.90 | 8,800 | 51,920 | 39,821 | 48.6 K to 39.8 K (-18.10 %) |
Nov 28 2006 | AVGN | AVIGEN INC \DE | IWAKI YUICHI | Director | Sell | S | 5.98 | 400 | 2,392 | 48,621 | 49 K to 48.6 K (-0.82 %) |
Nov 28 2006 | AVGN | AVIGEN INC \DE | IWAKI YUICHI | Director | Sell | S | 5.97 | 2,374 | 14,173 | 49,021 | 51.4 K to 49 K (-4.62 %) |
Nov 28 2006 | AVGN | AVIGEN INC \DE | IWAKI YUICHI | Director | Sell | S | 5.96 | 600 | 3,576 | 51,395 | 52 K to 51.4 K (-1.15 %) |
Nov 28 2006 | AVGN | AVIGEN INC \DE | IWAKI YUICHI | Director | Sell | S | 5.95 | 5,826 | 34,665 | 51,995 | 57.8 K to 52 K (-10.08 %) |
Nov 28 2006 | AVGN | AVIGEN INC \DE | IWAKI YUICHI | Director | Sell | S | 5.94 | 400 | 2,376 | 57,821 | 58.2 K to 57.8 K (-0.69 %) |
Nov 28 2006 | AVGN | AVIGEN INC \DE | IWAKI YUICHI | Director | Sell | S | 5.91 | 300 | 1,773 | 58,221 | 58.5 K to 58.2 K (-0.51 %) |
Nov 28 2006 | AVGN | AVIGEN INC \DE | IWAKI YUICHI | Director | Sell | S | 5.90 | 1,100 | 6,490 | 58,521 | 59.6 K to 58.5 K (-1.84 %) |
Oct 25 2006 | AVGN | AVIGEN INC \DE | IWAKI YUICHI | Director | Option Exercise | M | 2.00 | 3,350 | 6,700 | 0 | |
Oct 25 2006 | AVGN | AVIGEN INC \DE | IWAKI YUICHI | Director | Option Exercise | M | 3.25 | 1,650 | 5,363 | 0 | |
Oct 25 2006 | AVGN | AVIGEN INC \DE | IWAKI YUICHI | Director | Option Exercise | M | 4.00 | 3,750 | 15,000 | 0 | |
Oct 25 2006 | AVGN | AVIGEN INC \DE | IWAKI YUICHI | Director | Option Exercise | M | 3.63 | 2,500 | 9,063 | 0 | |
Oct 25 2006 | AVGN | AVIGEN INC \DE | IWAKI YUICHI | Director | Buy | M | 2.00 | 3,350 | 6,700 | 59,621 | 56.3 K to 59.6 K (+5.95 %) |
Oct 25 2006 | AVGN | AVIGEN INC \DE | IWAKI YUICHI | Director | Buy | M | 3.25 | 1,650 | 5,363 | 56,271 | 54.6 K to 56.3 K (+3.02 %) |
Oct 25 2006 | AVGN | AVIGEN INC \DE | IWAKI YUICHI | Director | Buy | M | 4.00 | 3,750 | 15,000 | 54,621 | 50.9 K to 54.6 K (+7.37 %) |
Oct 25 2006 | AVGN | AVIGEN INC \DE | IWAKI YUICHI | Director | Buy | M | 3.63 | 2,500 | 9,063 | 50,871 | 48.4 K to 50.9 K (+5.17 %) |
Jun 01 2006 | AVGN | AVIGEN INC \DE | Wallace Richard John | Director | Option Exercise | A | 5.41 | 5,000 | 27,050 | 5,000 | |
Jun 01 2006 | AVGN | AVIGEN INC \DE | VAPNEK DANIEL | Director | Option Exercise | A | 5.41 | 20,000 | 108,200 | 20,000 | |
Jun 01 2006 | AVGN | AVIGEN INC \DE | IWAKI YUICHI | Director | Option Exercise | A | 5.41 | 20,000 | 108,200 | 20,000 | |
Jun 01 2006 | AVGN | AVIGEN INC \DE | PRENDERGAST JOHN K A | Director | Option Exercise | A | 5.41 | 20,000 | 108,200 | 40,000 | |
Jun 01 2006 | AVGN | AVIGEN INC \DE | HOROVITZ ZOLA P | Director | Option Exercise | A | 5.41 | 40,000 | 216,400 | 40,000 | |
Apr 19 2006 | AVGN | AVIGEN INC \DE | MCGUIRE DAWN | Chief Medical Offic ... | Option Exercise | M | 3.14 | 3,093 | 9,712 | 0 | |
Apr 19 2006 | AVGN | AVIGEN INC \DE | MCGUIRE DAWN | Chief Medical Offic ... | Sell | S | 6.22 | 10,937 | 68,058 | 3,093 | 14 K to 3.1 K (-77.95 %) |
Apr 19 2006 | AVGN | AVIGEN INC \DE | MCGUIRE DAWN | Chief Medical Offic ... | Buy | M | 3.14 | 3,093 | 9,712 | 3,093 | 0 to 3.1 K |
Mar 22 2006 | AVGN | AVIGEN INC \DE | Wallace Richard John | Director | Option Exercise | A | 5.55 | 30,000 | 166,500 | 30,000 | |
Mar 10 2006 | AVGN | AVIGEN INC \DE | IWAKI YUICHI | Director | Sell | S | 5.65 | 660 | 3,729 | 48,371 | 49 K to 48.4 K (-1.35 %) |
Mar 10 2006 | AVGN | AVIGEN INC \DE | IWAKI YUICHI | Director | Sell | S | 5.64 | 1,100 | 6,204 | 49,031 | 50.1 K to 49 K (-2.19 %) |
Mar 10 2006 | AVGN | AVIGEN INC \DE | IWAKI YUICHI | Director | Sell | S | 5.63 | 300 | 1,689 | 50,131 | 50.4 K to 50.1 K (-0.59 %) |
Mar 10 2006 | AVGN | AVIGEN INC \DE | IWAKI YUICHI | Director | Sell | S | 5.62 | 3,703 | 20,811 | 50,431 | 54.1 K to 50.4 K (-6.84 %) |
Mar 10 2006 | AVGN | AVIGEN INC \DE | IWAKI YUICHI | Director | Sell | S | 5.61 | 1,200 | 6,732 | 54,134 | 55.3 K to 54.1 K (-2.17 %) |
Mar 10 2006 | AVGN | AVIGEN INC \DE | IWAKI YUICHI | Director | Sell | S | 5.60 | 33,037 | 185,007 | 55,334 | 88.4 K to 55.3 K (-37.38 %) |
Mar 10 2006 | AVGN | AVIGEN INC \DE | IWAKI YUICHI | Director | Sell | S | 5.60 | 28,200 | 157,920 | 88,371 | 116.6 K to 88.4 K (-24.19 %) |
Mar 10 2006 | AVGN | AVIGEN INC \DE | IWAKI YUICHI | Director | Sell | S | 5.65 | 300 | 1,695 | 116,571 | 116.9 K to 116.6 K (-0.26 %) |
Mar 10 2006 | AVGN | AVIGEN INC \DE | IWAKI YUICHI | Director | Sell | S | 5.63 | 200 | 1,126 | 116,871 | 117.1 K to 116.9 K (-0.17 %) |
Mar 10 2006 | AVGN | AVIGEN INC \DE | IWAKI YUICHI | Director | Sell | S | 5.62 | 100 | 562 | 117,071 | 117.2 K to 117.1 K (-0.09 %) |
Mar 10 2006 | AVGN | AVIGEN INC \DE | IWAKI YUICHI | Director | Sell | S | 5.61 | 800 | 4,488 | 117,171 | 118 K to 117.2 K (-0.68 %) |
Mar 10 2006 | AVGN | AVIGEN INC \DE | IWAKI YUICHI | Director | Sell | S | 5.60 | 400 | 2,240 | 117,971 | 118.4 K to 118 K (-0.34 %) |
Mar 10 2006 | AVGN | AVIGEN INC \DE | IWAKI YUICHI | Director | Sell | S | 5.53 | 300 | 1,659 | 118,371 | 118.7 K to 118.4 K (-0.25 %) |
Mar 10 2006 | AVGN | AVIGEN INC \DE | IWAKI YUICHI | Director | Sell | S | 5.52 | 100 | 552 | 118,671 | 118.8 K to 118.7 K (-0.08 %) |
Mar 10 2006 | AVGN | AVIGEN INC \DE | IWAKI YUICHI | Director | Sell | S | 5.50 | 9,600 | 52,800 | 118,771 | 128.4 K to 118.8 K (-7.48 %) |
Feb 24 2006 | AVGN | AVIGEN INC \DE | SAUTER ANDREW AUGUST | VP, Finance | Option Exercise | A | 5.06 | 18,887 | 95,606 | 18,887 | |
Feb 24 2006 | AVGN | AVIGEN INC \DE | SAUTER ANDREW AUGUST | VP, Finance | Option Exercise | A | 5.06 | 31,113 | 157,494 | 31,113 | |
Feb 24 2006 | AVGN | AVIGEN INC \DE | MCGUIRE DAWN | Chief Medical Offic ... | Option Exercise | A | 5.06 | 53,828 | 272,477 | 53,828 | |
Feb 24 2006 | AVGN | AVIGEN INC \DE | MCGUIRE DAWN | Chief Medical Offic ... | Option Exercise | A | 5.06 | 61,172 | 309,653 | 61,172 | |
Feb 24 2006 | AVGN | AVIGEN INC \DE | Johnson Kirk William | VP, Preclinical Dev ... | Option Exercise | A | 5.06 | 53,828 | 272,477 | 53,828 | |
Feb 24 2006 | AVGN | AVIGEN INC \DE | Johnson Kirk William | VP, Preclinical Dev ... | Option Exercise | A | 5.06 | 61,172 | 309,653 | 61,172 | |
Feb 24 2006 | AVGN | AVIGEN INC \DE | Thomson Mary Christina | VP, Corporate Couns ... | Option Exercise | A | 5.06 | 53,828 | 272,477 | 53,828 | |
Feb 24 2006 | AVGN | AVIGEN INC \DE | Thomson Mary Christina | VP, Corporate Couns ... | Option Exercise | A | 5.06 | 61,172 | 309,653 | 61,172 | |
Feb 24 2006 | AVGN | AVIGEN INC \DE | COFFEE MICHAEL DENIS | Chief Business Offi ... | Option Exercise | A | 5.06 | 105,416 | 533,616 | 105,416 | |
Feb 24 2006 | AVGN | AVIGEN INC \DE | COFFEE MICHAEL DENIS | Chief Business Offi ... | Option Exercise | A | 5.06 | 9,584 | 48,514 | 9,584 | |
Feb 24 2006 | AVGN | AVIGEN INC \DE | CHAHINE KENNETH | Chief Executive Off ... | Option Exercise | A | 5.06 | 93,589 | 473,748 | 93,589 | |
Feb 24 2006 | AVGN | AVIGEN INC \DE | CHAHINE KENNETH | Chief Executive Off ... | Option Exercise | A | 5.06 | 56,411 | 285,552 | 56,411 | |
Feb 09 2006 | AVGN | AVIGEN INC \DE | HOROVITZ ZOLA P | Director | Option Exercise | A | 4.85 | 20,000 | 97,000 | 20,000 | |
Jan 20 2006 | AVGN | AVIGEN INC \DE | SAUTER ANDREW AUGUST | Vice President, Fin ... | Option Exercise | A | 3.16 | 50,000 | 158,000 | 50,000 | |
Jul 28 2005 | AVGN | AVIGEN INC \DE | WHITCOME PHILIP J | Chairman of the Boa ... | Option Exercise | M | 0.49 | 515,248 | 251,080 | 0 | |
Jul 28 2005 | AVGN | AVIGEN INC \DE | WHITCOME PHILIP J | Chairman of the Boa ... | Buy | M | 0.49 | 515,248 | 251,080 | 515,248 | 0 to 515.2 K |
Jul 06 2005 | AVGN | AVIGEN INC \DE | COFFEE MICHAEL DENIS | Chief Business Offi ... | Option Exercise | A | 3.14 | 5,250 | 16,485 | 5,250 | |
Jul 06 2005 | AVGN | AVIGEN INC \DE | COFFEE MICHAEL DENIS | Chief Business Offi ... | Option Exercise | A | 3.14 | 1,750 | 5,495 | 1,750 | |
Jul 06 2005 | AVGN | AVIGEN INC \DE | WHITCOME PHILIP J | Chairman of the Boa ... | Option Exercise | A | 3.14 | 11,666 | 36,631 | 11,666 | |
Jul 06 2005 | AVGN | AVIGEN INC \DE | Thomson Mary Christina | VP, Corporate Couns ... | Option Exercise | A | 3.14 | 16,500 | 51,810 | 16,500 | |
Jul 06 2005 | AVGN | AVIGEN INC \DE | Johnson Kirk William | VP, Preclinical Dev ... | Option Exercise | A | 3.14 | 16,500 | 51,810 | 16,500 | |
Jul 06 2005 | AVGN | AVIGEN INC \DE | MCGUIRE DAWN | Chief Medical Offic ... | Option Exercise | A | 3.14 | 16,500 | 51,810 | 16,500 | |
Jul 06 2005 | AVGN | AVIGEN INC \DE | PAULSON THOMAS J | Chief Finance Offic ... | Option Exercise | A | 3.14 | 9,900 | 31,086 | 9,900 | |
Jul 06 2005 | AVGN | AVIGEN INC \DE | CHAHINE KENNETH | Chief Executive Off ... | Option Exercise | A | 3.14 | 33,000 | 103,620 | 33,000 | |
May 27 2005 | AVGN | AVIGEN INC \DE | VAPNEK DANIEL | Director | Option Exercise | A | 2.96 | 10,000 | 29,600 | 10,000 | |
May 27 2005 | AVGN | AVIGEN INC \DE | IWAKI YUICHI | Director | Option Exercise | A | 2.96 | 10,000 | 29,600 | 10,000 | |
May 27 2005 | AVGN | AVIGEN INC \DE | HOROVITZ ZOLA P | Director | Option Exercise | A | 2.96 | 10,000 | 29,600 | 10,000 | |
May 27 2005 | AVGN | AVIGEN INC \DE | PRENDERGAST JOHN K A | Director | Option Exercise | A | 2.96 | 10,000 | 29,600 | 10,000 | |
Feb 25 2005 | AVGN | AVIGEN INC \DE | COFFEE MICHAEL DENIS | Chief Business Offi ... | Option Exercise | A | 2.86 | 7,605 | 21,750 | 150,000 | |
Feb 25 2005 | AVGN | AVIGEN INC \DE | COFFEE MICHAEL DENIS | Chief Business Offi ... | Option Exercise | A | 2.86 | 142,395 | 407,250 | 142,395 | |
Jun 29 2004 | AVGN | AVIGEN INC \DE | Johnson Kirk William | Assoc. VP, Preclini ... | Option Exercise | A | 3.38 | 50,000 | 169,000 | 50,000 | |
Jun 29 2004 | AVGN | AVIGEN INC \DE | Johnson Kirk William | Assoc. VP, Preclini ... | Option Exercise | A | 3.38 | 50,000 | 169,000 | 50,000 | |
Jun 29 2004 | AVGN | AVIGEN INC \DE | PAULSON THOMAS J | Chief Finance Offic ... | Option Exercise | A | 3.38 | 50,000 | 169,000 | 50,000 | |
Jun 29 2004 | AVGN | AVIGEN INC \DE | PIERCE GLENN | VP, Research & Clin ... | Option Exercise | A | 3.38 | 50,000 | 169,000 | 50,000 | |
Jun 29 2004 | AVGN | AVIGEN INC \DE | CHAHINE KENNETH | Chief Executive Off ... | Option Exercise | A | 3.38 | 125,000 | 422,500 | 125,000 | |
Jun 29 2004 | AVGN | AVIGEN INC \DE | WHITCOME PHILIP J | Chairman of the Boa ... | Option Exercise | A | 3.38 | 50,000 | 169,000 | 50,000 | |
Jun 29 2004 | AVGN | AVIGEN INC \DE | MCGUIRE DAWN | Chief Medical Offic ... | Option Exercise | A | 3.38 | 25,000 | 84,500 | 25,000 | |
Jun 29 2004 | AVGN | AVIGEN INC \DE | Thomson Mary Christina | VP, Corporate Couns ... | Option Exercise | A | 3.38 | 100,000 | 338,000 | 100,000 | |
May 28 2004 | AVGN | AVIGEN INC \DE | IWAKI YUICHI | Director | Option Exercise | A | 3.99 | 10,000 | 39,900 | 10,000 | |
May 28 2004 | AVGN | AVIGEN INC \DE | VAPNEK DANIEL | Director | Option Exercise | A | 3.99 | 10,000 | 39,900 | 10,000 | |
May 28 2004 | AVGN | AVIGEN INC \DE | PRENDERGAST JOHN K A | Director | Option Exercise | A | 3.99 | 10,000 | 39,900 | 10,000 | |
May 28 2004 | AVGN | AVIGEN INC \DE | HOROVITZ ZOLA P | Director | Option Exercise | A | 3.99 | 10,000 | 39,900 | 10,000 | |
Feb 20 2004 | AVGN | AVIGEN INC \DE | IWAKI YUICHI | Director | Sell | S | 7.50 | 1,028 | 7,710 | 128,371 | 129.4 K to 128.4 K (-0.79 %) |
Feb 20 2004 | AVGN | AVIGEN INC \DE | IWAKI YUICHI | Director | Sell | S | 7.50 | 1,972 | 14,790 | 129,399 | 131.4 K to 129.4 K (-1.50 %) |
Feb 18 2004 | AVGN | AVIGEN INC \DE | IWAKI YUICHI | Director | Option Exercise | M | 6.05 | 18,000 | 108,900 | 0 | |
Feb 18 2004 | AVGN | AVIGEN INC \DE | IWAKI YUICHI | Director | Sell | S | 7.40 | 1,600 | 11,840 | 131,371 | 133 K to 131.4 K (-1.20 %) |
Feb 18 2004 | AVGN | AVIGEN INC \DE | IWAKI YUICHI | Director | Sell | S | 7.50 | 7,000 | 52,500 | 132,971 | 140 K to 133 K (-5.00 %) |
Feb 18 2004 | AVGN | AVIGEN INC \DE | IWAKI YUICHI | Director | Sell | S | 7.30 | 1,400 | 10,220 | 139,971 | 141.4 K to 140 K (-0.99 %) |
Feb 18 2004 | AVGN | AVIGEN INC \DE | IWAKI YUICHI | Director | Buy | M | 6.05 | 18,000 | 108,900 | 141,371 | 123.4 K to 141.4 K (+14.59 %) |
Feb 17 2004 | AVGN | AVIGEN INC \DE | HOROVITZ ZOLA P | Director | Sell | S | 7.60 | 200 | 1,520 | 0 | 200 to 0 (-100.00 %) |
Feb 17 2004 | AVGN | AVIGEN INC \DE | HOROVITZ ZOLA P | Director | Sell | S | 7.60 | 1,465 | 11,134 | 200 | 1.7 K to 200 (-87.99 %) |
Feb 17 2004 | AVGN | AVIGEN INC \DE | HOROVITZ ZOLA P | Director | Sell | S | 7.52 | 2,000 | 15,047 | 1,665 | 3.7 K to 1.7 K (-54.57 %) |
Feb 17 2004 | AVGN | AVIGEN INC \DE | HOROVITZ ZOLA P | Director | Sell | S | 7.50 | 8,000 | 60,000 | 3,665 | 11.7 K to 3.7 K (-68.58 %) |
Feb 17 2004 | AVGN | AVIGEN INC \DE | HOROVITZ ZOLA P | Director | Sell | S | 7.45 | 1,300 | 9,685 | 11,665 | 13 K to 11.7 K (-10.03 %) |
Feb 17 2004 | AVGN | AVIGEN INC \DE | HOROVITZ ZOLA P | Director | Sell | S | 7.40 | 500 | 3,700 | 12,965 | 13.5 K to 13 K (-3.71 %) |
Feb 11 2004 | AVGN | AVIGEN INC \DE | HOROVITZ ZOLA P | Director | Option Exercise | M | 0.71 | 1,693 | 1,200 | 0 | |
Feb 11 2004 | AVGN | AVIGEN INC \DE | HOROVITZ ZOLA P | Director | Option Exercise | M | 2.00 | 5,000 | 10,000 | 0 | |
Feb 11 2004 | AVGN | AVIGEN INC \DE | HOROVITZ ZOLA P | Director | Option Exercise | M | 0.44 | 6,772 | 3,000 | 0 | |
Feb 11 2004 | AVGN | AVIGEN INC \DE | HOROVITZ ZOLA P | Director | Buy | M | 0.71 | 1,693 | 1,200 | 13,465 | 11.8 K to 13.5 K (+14.38 %) |
Feb 11 2004 | AVGN | AVIGEN INC \DE | HOROVITZ ZOLA P | Director | Buy | M | 2.00 | 5,000 | 10,000 | 11,772 | 6.8 K to 11.8 K (+73.83 %) |
Feb 11 2004 | AVGN | AVIGEN INC \DE | HOROVITZ ZOLA P | Director | Buy | M | 0.44 | 6,772 | 3,000 | 6,772 | 0 to 6.8 K |
Jan 22 2004 | AVGN | AVIGEN INC \DE | MCGUIRE DAWN | Chief Medical Offic ... | Option Exercise | A | 6.31 | 120,000 | 757,200 | 120,000 | |
Dec 17 2003 | AVGN | AVIGEN INC \DE | IWAKI YUICHI | Director | Sell | S | 6.39 | 209 | 1,336 | 123,371 | 123.6 K to 123.4 K (-0.17 %) |
Dec 17 2003 | AVGN | AVIGEN INC \DE | IWAKI YUICHI | Director | Sell | S | 6.36 | 1,400 | 8,904 | 123,580 | 125 K to 123.6 K (-1.12 %) |
Dec 17 2003 | AVGN | AVIGEN INC \DE | IWAKI YUICHI | Director | Sell | S | 6.35 | 391 | 2,483 | 124,980 | 125.4 K to 125 K (-0.31 %) |
Dec 17 2003 | AVGN | AVIGEN INC \DE | IWAKI YUICHI | Director | Sell | S | 6.34 | 36 | 228 | 125,371 | 125.4 K to 125.4 K (-0.03 %) |
Dec 17 2003 | AVGN | AVIGEN INC \DE | IWAKI YUICHI | Director | Sell | S | 6.32 | 100 | 632 | 125,407 | 125.5 K to 125.4 K (-0.08 %) |
Dec 17 2003 | AVGN | AVIGEN INC \DE | IWAKI YUICHI | Director | Sell | S | 6.31 | 100 | 631 | 125,507 | 125.6 K to 125.5 K (-0.08 %) |
Dec 17 2003 | AVGN | AVIGEN INC \DE | IWAKI YUICHI | Director | Sell | S | 6.30 | 14,415 | 90,815 | 125,607 | 140 K to 125.6 K (-10.29 %) |
Dec 17 2003 | AVGN | AVIGEN INC \DE | IWAKI YUICHI | Director | Sell | S | 6.28 | 5,000 | 31,400 | 140,022 | 145 K to 140 K (-3.45 %) |
Dec 17 2003 | AVGN | AVIGEN INC \DE | IWAKI YUICHI | Director | Sell | S | 6.26 | 3,349 | 20,965 | 145,022 | 148.4 K to 145 K (-2.26 %) |